A new book inspires readers to seek ways to apply NMR spectroscopy to their own purposes.
Susan J. Schniepp
Advertisement
Susan J. Schniepp is a fellow at Regulatory Compliance Associates, Inc. and a member of Pharmaceutical Technology's Editorial Advisory Board.
Articles by Susan J. Schniepp
The USP public-comment process exists for a reason. Industry needs to take advantage. This article contains bonus online-exclusive material.
The growth and globalization of the pharmaceutical supply chain make risk assessment more important than ever for pharmaceutical manufacturers. The authors describe a program to identify, prioritize, mitigate, and communicate risks in manufacturer–supplier relationships.
PTSM: Pharmaceutical Technology Sourcing and Management
Providing the right information upfront may ease new requirements to assess solvent levels.
Providing the right information upfront may ease new requirements to assess solvent levels.
The authors dispel common misinterpretations of the United States Pharmacopeia.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Impurity Deficiencies Keep Repeating: AAPS PharmSci 360 2026
2
PharmSci 360: Build the Device Into Dosage Form Development From Day One
3
CDMOs, OEMs, and Used Equipment Resellers are Joining Forces to Onshore Pharmaceutical Manufacturing
4
ADCs, Degraders, Agonists: 4 Deals CMC Teams Should Track
5